Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000808 citationsPatrick L. Fitzgibbons, Donald L. Weaver et al.Archives of Pathology & Laboratory Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of F P O’Malley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F P O’Malley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F P O’Malley more than expected).
This network shows the impact of papers produced by F P O’Malley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F P O’Malley. The network helps show where F P O’Malley may publish in the future.
Co-authorship network of co-authors of F P O’Malley
This figure shows the co-authorship network connecting the top 25 collaborators of F P O’Malley.
A scholar is included among the top collaborators of F P O’Malley based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F P O’Malley. F P O’Malley is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Mohsin, S K, et al.. (2005). Assessment of variability in diagnosing "Atypia" in columnar cell lesions (CCL) of the breast. Laboratory Investigation. 18.3 indexed citations
Fitzgibbons, Patrick L., Donald L. Weaver, AD Thor, et al.. (2000). Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.. Archives of Pathology & Laboratory Medicine. 124(7). 966–78.808 indexed citations breakdown →
11.
Tonkin, Katia, et al.. (1997). Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study.. PubMed. 20(5). 300–7.10 indexed citations
12.
Singhal, Hemant, D Bautista, Katia Tonkin, et al.. (1997). Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.. PubMed. 3(4). 605–11.251 indexed citations
13.
Tuck, Alan B., F P O’Malley, Hemant Singhal, et al.. (1997). Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.. PubMed. 121(6). 578–84.93 indexed citations
14.
Simpson, Jean F., et al.. (1997). Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.. PubMed. 151(1). 161–8.74 indexed citations
15.
O’Malley, F P, et al.. (1994). p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.. PubMed. 71(1). 67–72.66 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.